Capital Group International Developed Eq (S:0P0001RQ7N)
115.18
+1.85
(+1.63%)
USD |
Dec 31 2025
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of January 14, 2026.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Safran SA | 3.25% | 93.45 | -2.70% |
| Rolls-Royce Holdings Plc | 3.03% | 17.32 | -1.95% |
| SAP SE | 2.59% | 237.77 | -3.78% |
| ABB Ltd. | 2.55% | 74.91 | -1.37% |
| Taiwan Semiconductor Manufacturing Co., Ltd. | 2.52% | 326.14 | -1.53% |
| ASML Holding NV | 2.50% | 1260.74 | -0.74% |
| EssilorLuxottica SA | 2.31% | 162.72 | 0.59% |
| UniCredit SpA | 2.18% | 41.54 | -0.29% |
| Novo Nordisk A/S | 2.04% | 58.79 | -1.43% |
| AstraZeneca PLC | 1.93% | 95.91 | 1.48% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Attributes | |
| Socially Responsible Fund | -- |